CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 77 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4 | -55.6% | 4,144 | -63.8% | 0.00% | – |
| Q4 2023 | $9 | 0.0% | 11,447 | -9.7% | 0.00% | – |
| Q3 2023 | $9 | -40.0% | 12,680 | 0.0% | 0.00% | – |
| Q2 2023 | $15 | -99.9% | 12,680 | -7.7% | 0.00% | – |
| Q1 2022 | $25,000 | -45.7% | 13,731 | -53.6% | 0.00% | – |
| Q4 2021 | $46,000 | +48.4% | 29,570 | +93.4% | 0.00% | – |
| Q3 2021 | $31,000 | -44.6% | 15,289 | -4.3% | 0.00% | – |
| Q2 2021 | $56,000 | – | 15,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 61,613 | $48,674 | 0.00% |
| Kestra Advisory Services, LLC | 93,717 | $74,036 | 0.00% |